Skip to main content
RVMD
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai•Reviewed by Editorial Team
Sentiment info
Neutral
Importance info
4
Price
$143.5
Mkt Cap
$27.484B
52W Low
$34
52W High
$155.7
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, RVMD was trading at $143.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27.5B. The 52-week trading range was $34.00 to $155.70. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RVMD - Latest Insights

RVMD
Apr 17, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Revolution Medicines Formally Issues $500M Convertible Notes at Premium Above 52-Week High
Sentiment: Positive
View Wiseek Article
RVMD
Apr 17, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
7
Revolution Medicines Closes Upsized $2.2 Billion Offering, Underwriters Fully Exercise Option
Sentiment: Positive
View Wiseek Article
RVMD
Apr 16, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
9
Revolution Medicines Secures $2.15B in Capital, Upsizing Stock Offering to $1.65B
Sentiment: Positive
View Wiseek Article
RVMD
Apr 16, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Revolution Medicines Closes $1.65B Equity Offering, Secures $500M Convertible Notes for $2.14B Total Capital Raise
Sentiment: Neutral
View Wiseek Article
RVMD
Apr 15, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
9
Revolution Medicines Prices $1.5B Common Stock Offering and $500M Convertible Notes, Raising $1.92B Total
Sentiment: Neutral
View Wiseek Article
RVMD
Apr 15, 2026, 5:24 PM EDT
Filing Type: 424B5
Importance Score:
9
Revolution Medicines Finalizes Upsized $1.92 Billion Capital Raise via Convertible Notes and Common Stock Offerings
Sentiment: Positive
View Wiseek Article
RVMD
Apr 15, 2026, 6:00 AM EDT
Filing Type: FWP
Importance Score:
9
Revolution Medicines Prices $2.0 Billion Offering, Upsizing Capital Raise for Pipeline Development
Sentiment: Positive
View Wiseek Article
RVMD
Apr 15, 2026, 12:41 AM EDT
Source: GlobeNewswire
Importance Score:
9
Revolution Medicines Prices Upsized $2 Billion Stock and Convertible Note Offerings
Sentiment: Neutral
View Wiseek Article
RVMD
Apr 13, 2026, 4:39 PM EDT
Filing Type: 424B5
Importance Score:
8
Revolution Medicines Launches $1 Billion Capital Raise Following Positive Clinical Trial Results
Sentiment: Neutral
View Wiseek Article
RVMD
Apr 13, 2026, 4:36 PM EDT
Filing Type: 424B5
Importance Score:
9
Revolution Medicines Files for $1 Billion Concurrent Stock and Convertible Note Offering Following Positive Clinical Trial Results
Sentiment: Positive
View Wiseek Article